Secondary Logo

Journal Logo

Most Emailed Articles

Comparing Injectable DaxibotulinumtoxinA and OnabotulinumtoxinA in Moderate and Severe Glabellar Lines: Additional Analyses From a Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Study

Bertucci, Vince; Humphrey, Shannon; Carruthers, Jean; More

Dermatologic Surgery. 43:S262-S273, December 2017.

Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo

Carruthers, Jean; Solish, Nowell; Humphrey, Shannon; More

Dermatologic Surgery. 43(11):1321-1331, November 2017.

Efficacy and Safety of OnabotulinumtoxinA for Treating Crow's Feet Lines Alone or in Combination With Glabellar Lines: A Multicenter, Randomized, Controlled Trial

Moers-Carpi, Marion; Carruthers, Jean; Fagien, Steven; More

Dermatologic Surgery. 41(1):102-112, January 2015.